Evonik reaches milestone with permanently implantable Vestakeep Peek


Evonik Corporation announced that each of its primary implantable Vestakeep Peek product lines have been referenced in customer products that have received US Food and Drug Administration’s (FDA) 510(k) clearance for permanent implant use.

“We are excited about the growing interest Vestakeep Peek is receiving within the medical device industry,” says Peter Colburn, director of Evonik’s Vestapeek implant product lines. “It is clear that medical device manufacturers need innovative companies like Evonik to create materials and offer services meeting their specific needs. Vestakeep Peek is known for its superior biocompatibility, biostability, and combination of stiffness and ductility, making it not only a unique polymer but also an excellent material for medical implant applications.”

The product lines used in medical devices that have received FDA 510(k) clearance include Vestakeep i2G Resin for injection moulding applications, Vestakeep i4G Resin for injection moulding and extrusion applications, and Vestakeep i4R Stock Shape for machined implant applications.

Products using Vestakeep Peek that have already received FDA 510(k) clearance cover a broad range of applications including spinal implants, suture anchors, cranial implants, pharmaceutical drug delivery devices and implantable MRI markers supporting image-guided cancer treatment procedures.


According to a company release, several Vestakeep Peek products are in development and planned for launch this year including Vestakeep Peek with Barium Sulfate (BaSO4) and Vestakeep Peek with Carbon Fibre.